Growth Metrics

Ultragenyx Pharmaceutical (RARE) Free Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 66.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 137.65%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -18.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.56%
Dec 31, 2025 -25.53%
Sep 30, 2025 -27.10%
Jun 30, 2025 -45.64%
Mar 31, 2025 13.02%
Dec 31, 2024 -54.53%
Sep 30, 2024 52.79%
Jun 30, 2024 32.28%
Mar 31, 2024 -15.66%
Dec 31, 2023 41.47%
Sep 30, 2023 -66.53%
Jun 30, 2023 -49.80%
Mar 31, 2023 -16.66%
Dec 31, 2022 -24.83%
Sep 30, 2022 -15.65%
Jun 30, 2022 11.63%
Mar 31, 2022 19.04%
Dec 31, 2021 16.60%
Sep 30, 2021 -22.00%
Jun 30, 2021 -202.59%
Mar 31, 2021 -60.88%
Dec 31, 2020 -1.03%
Sep 30, 2020 29.71%
Jun 30, 2020 188.30%
Mar 31, 2020 -10.54%
Dec 31, 2019 -46.44%
Sep 30, 2019 -33.27%
Jun 30, 2019 -21.75%
Mar 31, 2019 -9.87%
Dec 31, 2018 28.99%
Sep 30, 2018 -11.37%
Jun 30, 2018 -57.44%
Mar 31, 2018 -45.81%
Dec 31, 2017 -109.71%
Sep 30, 2017 -98.53%
Jun 30, 2017 -10.07%
Mar 31, 2017 -33.03%
Dec 31, 2016 9.59%
Sep 30, 2016 2.56%
Jun 30, 2016 -150.16%
Mar 31, 2016 -155.94%
Dec 31, 2015 -285.12%
Sep 30, 2015 -159.95%
Jun 30, 2015 -75.99%
Mar 31, 2015 -61.91%
Dec 31, 2014 -11.10%
Sep 30, 2014 -80.33%
Jun 30, 2014 -22.55%
Mar 31, 2014 -72.95%